Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122474172 | 12247417 | 2 | F | 20160824 | 20160407 | 20160829 | EXP | AU-ABBVIE-16P-008-1599987-00 | ABBVIE | 57.00 | YR | M | Y | 0.00000 | 20160829 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122474172 | 12247417 | 1 | PS | VALPROATE SODIUM. | VALPROATE SODIUM | 1 | Unknown | U | UNKNOWN | 18081 | |||||||||
| 122474172 | 12247417 | 2 | SS | CLOZARIL | CLOZAPINE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 122474172 | 12247417 | 3 | SS | MAGNESIUM ASPARTATE | MAGNESIUM ASPARTATE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 122474172 | 12247417 | 4 | SS | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 122474172 | 12247417 | 5 | SS | PROPRANOLOL HYDROCHLORIDE. | PROPRANOLOL HYDROCHLORIDE | 1 | Unknown | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122474172 | 12247417 | 1 | Product used for unknown indication |
| 122474172 | 12247417 | 2 | Product used for unknown indication |
| 122474172 | 12247417 | 3 | Product used for unknown indication |
| 122474172 | 12247417 | 4 | Product used for unknown indication |
| 122474172 | 12247417 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122474172 | 12247417 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122474172 | 12247417 | Antipsychotic drug level below therapeutic | |
| 122474172 | 12247417 | Blood creatine phosphokinase increased | |
| 122474172 | 12247417 | Blood creatinine decreased | |
| 122474172 | 12247417 | Blood glucose increased | |
| 122474172 | 12247417 | Blood lactate dehydrogenase increased | |
| 122474172 | 12247417 | Blood osmolarity increased | |
| 122474172 | 12247417 | Blood phosphorus increased | |
| 122474172 | 12247417 | Blood urea increased | |
| 122474172 | 12247417 | Blood urea nitrogen/creatinine ratio increased | |
| 122474172 | 12247417 | Constipation | |
| 122474172 | 12247417 | Monocyte count increased | |
| 122474172 | 12247417 | Nocturia | |
| 122474172 | 12247417 | Parkinsonism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |